Table 5 Logistic regression models results for male breast cancer (MBC) patients in the year-of-birth matched cohort.
From: Unveiling the comorbidity burden of male breast cancer
Comorbidity | Prevalence | Crude OR | p-value |
|---|---|---|---|
(n, %) | (95% CI) | ||
Disorders of lipid metabolism | 58 (55.24) | 1.65 (1.03-2.64) | 0.039* |
Hypertension | 52 (49.52) | 0.71 (0.44-1.13) | 0.150 |
Other nutritional; endocrine; and metabolic disorders | 34 (32.38) | 1.14 (0.69-1.89) | 0.604 |
Diabetes Mellitus | 30 (28.57) | 0.95 (0.57-1.60) | 0.861 |
Anxiety disorders | 22 (20.95) | 2.05 (1.09-3.87) | 0.026* |
Cardiac dysrhythmias | 21 (20.00) | 1.63 (0.87-3.03) | 0.126 |
Genitourinary symptoms and ill-defined conditions | 21 (20.00) | 2.03 (1.07-3.87) | 0.031* |
Osteoarthritis | 21 (20.00) | 0.89 (0.5-1.59) | 0.697 |
Cataract | 17 (16.19) | 0.85 (0.45-1.58) | 0.603 |
Obesity | 17 (16.19) | 1.26 (0.65-2.42) | 0.495 |
Hyperplasia of prostate | 16 (15.24) | 0.93 (0.49-1.78) | 0.827 |
Other ear and sense organ disorders | 14 (13.33) | 0.96 (0.48-1.91) | 0.908 |
Coagulation and hemorrhagic disorders | 13 (12.38) | 1.15 (0.56-2.37) | 0.707 |
Thyroid disorders | 12 (11.43) | 1.68 (0.76-3.73) | 0.204 |
Acute myocardial infarction | 12 (11.43) | 1.96 (0.86-4.45) | 0.110 |
Depression and mood disorders | 12 (11.43) | 0.95 (0.46-1.99) | 0.902 |
Glaucoma | 10 (9.52) | 0.86 (0.39-1.87) | 0.697 |
Chronic obstructive pulmonary disease and bronchiectasis | 10 (9.52) | 0.82 (0.37-1.78) | 0.608 |
Osteoporosis | 10 (9.52) | 3.58 (1.26-10.14) | 0.016* |
Delirium, dementia, and amnestic and other cognitive disorders | 10 (9.52) | 0.86 (0.39-1.87) | 0.697 |
Chronic kidney disease | 9 (8.57) | 1.14 (0.48-2.67) | 0.768 |
Gout and other crystal arthropathies | 8 (7.62) | 0.70 (0.30-1.64) | 0.417 |
Blindness and vision defects | 8 (7.62) | 0.83 (0.35-1.96) | 0.670 |
Congestive heart failure; nonhypertensive | 8 (7.62) | 1.84 (0.69-4.92) | 0.223 |
Other upper respiratory disease | 8 (7.62) | 1.65 (0.63-4.31) | 0.307 |
Spondylosis; intervertebral disc disorders; other back problems | 8 (7.62) | 0.70 (0.30-1.64) | 0.417 |
Asthma | 7 (6.67) | 1.60 (0.58-4.41) | 0.368 |
Chronic ulcer of skin | 7 (6.67) | 1.60 (0.58-4.41) | 0.368 |
Heart valve disorders | 6 (5.71) | 1.53 (0.52-4.53) | 0.442 |
Diverticulosis and diverticulitis | 6 (5.71) | 2.48 (0.74-8.34) | 0.141 |
Headache; including migraine | 5 (4.76) | 0.53 (0.19-1.48) | 0.227 |
Miscellaneous mental health disorders | 5 (4.76) | 0.83 (0.28-2.41) | 0.725 |
Cancer of bronchus; lung | 4 (3.81) | 8.28 (0.91-75.01) | 0.060 |
Cancer of prostate | 4 (3.81) | 0.48 (0.16-1.47) | 0.200 |
Epilepsy; convulsions | 4 (3.81) | 2.73 (0.6-12.44) | 0.194 |
Retinal detachments; defects; vascular occlusion; and retinopathy | 4 (3.81) | 1.62 (0.43-6.18) | 0.477 |
Acute cerebrovascular disease | 4 (3.81) | 0.60 (0.19-1.89) | 0.383 |
Peripheral and visceral atherosclerosis | 4 (3.81) | 1.35 (0.37-4.88) | 0.651 |
Aortic; peripheral; and visceral artery aneurysms | 4 (3.81) | 8.28 (0.91-75.01) | 0.060 |
Other diseases of veins and lymphatics | 4 (3.81) | omitted | |
Esophageal disorders | 4 (3.81) | 0.88 (0.27-2.94) | 0.841 |
Other inflammatory condition of skin | 4 (3.81) | 1.35 (0.37-4.88) | 0.651 |
Residual codes; unclassified | 4 (3.81) | 0.79 (0.24-2.59) | 0.700 |
Other endocrine disorders | 3 (2.86) | omitted | |
Other nervous system disorders | 3 (2.86) | 2.03 (0.4-10.23) | 0.391 |
Peri-; endo-; and myocarditis; cardiomyopathy (except that caused by tuberculosis or sexually transmitted disease) | 3 (2.86) | 2.03 (0.4-10.23) | 0.391 |
Transient cerebral ischemia | 3 (2.86) | 0.66 (0.17-2.48) | 0.535 |
Other liver diseases | 3 (2.86) | 1.00 (0.25-4.08) | 1.000 |
Alcohol-related disorders | 3 (2.86) | 0.74 (0.19-2.86) | 0.665 |
